Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1998
11/11/1998EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
11/11/1998EP0876372A1 Heteroarylcarboxamide derivatives
11/11/1998EP0876368A1 Use of mono- or diketone tetracyclic derivatives, resulting novel compounds and therapeutical use thereof
11/11/1998EP0876367A1 Trans apovincaminic acid ester derivatives as drugs
11/11/1998EP0876366A2 Angiogenesis inhibiting pyridazinamines
11/11/1998EP0876365A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
11/11/1998EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998EP0876356A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
11/11/1998EP0876355A1 2-thioxo-imidazolidin-4-one derivatives and their use for increasing hdl cholesterol concentration
11/11/1998EP0876343A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
11/11/1998EP0766570A4 Methods for treating respiratory disease
11/11/1998EP0693921A4 Anti-oxidant alkylaryl polyether alcohol polymers
11/11/1998CN1198775A Recombinant c-proteinase and processes, methods and uses thereof
11/11/1998CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998CN1198746A Tricyclic benzazepine vasopressin antagonists
11/11/1998CN1198741A Imidazole derivatives having affinity for alpha 2 receptors activity
11/11/1998CN1198673A Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
11/11/1998CN1198668A Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
11/11/1998CN1198667A Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis
11/11/1998CN1198347A Tankangning medicine for curing hemiplegia and making method
11/11/1998CN1198342A Medicine series for preventing and curing hypotension, angiocardiopathy and cerebrovascular disease and productive method thereof
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/11/1998CN1040645C Compound with 5-HT4 receptor rivalry activity, its preparation and pharmaceutical composition containing said compound
11/10/1998US5834596 Process for purifying ApoA or ApoE
11/10/1998US5834571 Gas phase polymerization process
11/10/1998US5834508 Ketone derivatives
11/10/1998US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998US5834503 Administering doses of green porphyrin in the absence of purposeful irradiation with light
11/10/1998US5834493 Treatment of nervous system disorders
11/10/1998US5834487 Inhibition of 26S and 20S proteasome by indanones
11/10/1998US5834483 Method of treating heart failure with endothelin antagonists
11/10/1998US5834481 Hypotensive agents
11/10/1998US5834469 Endothelin receptor antagonists
11/10/1998US5834440 Administering to human muscle cell an effective amount of dna to favor transcription of the dna to produce ribozyme
11/10/1998US5834425 Composite of lectin and epidermal growth factor domains, treatment of pathological leukocyte mediated inflammation
11/10/1998US5834419 Chemokine binding protein and methods of use therefor
11/10/1998US5834248 Treatment and diagnosis of cardiovascular disease
11/10/1998US5834238 Human GTP binding protein
11/10/1998US5834188 For inducing human osteogenic protein 1
11/10/1998US5834010 Triacetin as a penetration enhancer for transdermal delivery of a basic drug
11/10/1998US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
11/10/1998CA2145682C 2-substituted adenosines with a-2 receptor affinity
11/09/1998CA2237052A1 Substituted diaminocarboxylic acids
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049333A2 Eukaryotic gene expression cassette and uses thereof
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049300A2 Truncated vegf-related proteins
11/05/1998WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998049131A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
11/05/1998WO1998048822A1 Improved methods for processing activated protein c
11/05/1998WO1998048818A1 Activated protein c formulations
11/05/1998WO1998048812A1 Use of anabolic steroid derivatives in the treatment of chronic heart failure
11/05/1998WO1998043618A3 Use of cytoskeletal inhibitors for the prevention of restenosis
11/05/1998WO1998034583A3 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
11/05/1998WO1998033920A3 Tissue factor pathway inhibitor-3
11/05/1998WO1998033798A3 Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
11/05/1998WO1998032863A3 Mammalian thioredoxin
11/05/1998WO1998013349A3 Heteroaryloxyethylamines as 5-ht1a ligands
11/05/1998DE19720162A1 Mittel zur Steigerung der Herzkraft Means of increasing the myocardial contractile force
11/05/1998DE19718334A1 Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New benzylamine derivatives and phenylethylamine derivatives, processes for their preparation and their use as medicaments
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2287538A1 Truncated vegf-related proteins
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/04/1998EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998EP0875568A1 Novel human neurotensin receptor type 2 and splice variants thereof
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0875563A2 Improved methods for processing activated protein C
11/04/1998EP0875252A2 Activated protein C formulations
11/04/1998EP0874851A2 Macrocyclic compounds made from suboxide units
11/04/1998EP0874849A1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
11/04/1998EP0874844A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
11/04/1998EP0874829A1 Amino acid derivatives, the preparation and use thereof as endothelin antagonists
11/04/1998EP0874824A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874823A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874800A1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
11/04/1998EP0874624A2 Hyaluronic acid receptors binding agents and the use thereof
11/04/1998EP0705244B1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
11/04/1998EP0619802B1 A mixture of higher primary aliphatic alcohols and its pharmaceutical uses
11/04/1998EP0552227B2 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
11/04/1998CN1197654A Cardio- and cerebro-angiopathy curing drop pellet and its preparation
11/04/1998CN1040505C Method for prep. of antihypertensive composition
11/03/1998US5831115 Inhibitors of squalene synthase and protein farnesyltransferase
11/03/1998US5830920 Prevention growth of smooth muscle cells
11/03/1998US5830915 Oral diseases; skin disorders; antiinflammatory agents
11/03/1998US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998US5830896 Psychological disorders; antiepilepic agents; alzheimer'sand parkinson?s disease
11/03/1998US5830892 Piperidine and morphonline derivatives and their use as therapeutic agents
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998US5830703 DNA encoding adrenomedullin
11/03/1998US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998US5830468 Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
11/03/1998US5830463 Yeast-based delivery vehicles
11/03/1998US5830436 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
11/03/1998CA1340112C Supression of cell proliferation by decorin
11/01/1998CA2236128A1 Novel compounds
1 ... 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 ... 1595